Charles Pendley

2.2k total citations
31 papers, 1.7k citations indexed

About

Charles Pendley is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Charles Pendley has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Charles Pendley's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Dermatology and Skin Diseases (5 papers). Charles Pendley is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Psoriasis: Treatment and Pathogenesis (6 papers) and Dermatology and Skin Diseases (5 papers). Charles Pendley collaborates with scholars based in United States, Belgium and France. Charles Pendley's co-authors include Gopi Shankar, Mary Ann Mascelli, Kathryn E. Stein, Daniel E. Everitt, Kevin D. Cooper, Thomas S. McCormick, Bart Frederick, Eiko Toichi, Alice B. Gottlieb and Honghui Zhou and has published in prestigious journals such as Nature Biotechnology, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Charles Pendley

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Pendley United States	20	926	438	376	283	263	31	1.7k
Joseph C. Marini United States	17	748 0.8×	376 0.9×	266 0.7×	363 1.3×	60 0.2×	29	1.5k
Garvin L. Warner United States	21	807 0.9×	349 0.8×	251 0.7×	137 0.5×	70 0.3×	36	1.4k
Scott Mellis United States	16	858 0.9×	1.3k 3.1×	339 0.9×	336 1.2×	61 0.2×	33	2.7k
Satoshi Nunomura Japan	19	1.0k 1.1×	437 1.0×	106 0.3×	334 1.2×	273 1.0×	80	2.0k
Isabella Tosi United Kingdom	15	986 1.1×	327 0.7×	52 0.1×	148 0.5×	401 1.5×	29	1.8k
David G. Williams United Kingdom	24	565 0.6×	748 1.7×	607 1.6×	270 1.0×	23 0.1×	80	2.1k
Damien Ambrosetti France	26	199 0.2×	867 2.0×	181 0.5×	99 0.3×	268 1.0×	90	2.3k
Niels H. H. Heegaard Denmark	23	323 0.3×	780 1.8×	120 0.3×	239 0.8×	31 0.1×	48	1.5k
Elizabeth M. Kudlacz United States	21	693 0.7×	337 0.8×	41 0.1×	622 2.2×	84 0.3×	55	1.8k
D.W. van Bekkum Netherlands	19	467 0.5×	379 0.9×	210 0.6×	59 0.2×	45 0.2×	85	1.5k

Countries citing papers authored by Charles Pendley

Since Specialization

Citations

This map shows the geographic impact of Charles Pendley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Pendley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Pendley more than expected).

Fields of papers citing papers by Charles Pendley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Pendley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Pendley. The network helps show where Charles Pendley may publish in the future.

Co-authorship network of co-authors of Charles Pendley

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Pendley. A scholar is included among the top collaborators of Charles Pendley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Pendley. Charles Pendley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Chao, Thomas McIntosh, Thomas A. Puchalski, et al.. (2013). A Novel Approach to Evaluate the Pharmacokinetic Biocomparability of a Monoclonal Antibody Derived from Two Different Cell Lines Using Simultaneous Crossover Design. The AAPS Journal. 16(1). 125–128. 3 indexed citations

McIntosh, Thomas, et al.. (2013). A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines. mAbs. 5(1). 150–161. 4 indexed citations

Benson, Jacqueline, Clifford Sachs, George Treacy, et al.. (2011). Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab. Nature Biotechnology. 29(7). 615–624. 104 indexed citations

Xu, Zhenhua, Chaoying Hu, Daniel L. Baker, et al.. (2010). Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity. International Journal of Clinical Pharmacology and Therapeutics. 48(9). 596–607. 45 indexed citations

Zhu, Yaowei, et al.. (2010). Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis. International Journal of Clinical Pharmacology and Therapeutics. 48(12). 830–846. 23 indexed citations

Zhou, Honghui, Haishan Jang, Roy Fleischmann, et al.. (2007). Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 47(3). 383–396. 149 indexed citations

Shankar, Gopi, Charles Pendley, & Kathryn E. Stein. (2007). A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nature Biotechnology. 25(5). 555–561. 183 indexed citations

Toichi, Eiko, Gisela Torres, Thomas S. McCormick, et al.. (2006). An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis. The Journal of Immunology. 177(7). 4917–4926. 168 indexed citations

Tschaplinski, Timothy J., Gerald A. Tuskan, Mitchell M. Sewell, et al.. (2006). Phenotypic variation and quantitative trait locus identification for osmotic potential in an interspecific hybrid inbred F2 poplar pedigree grown in contrasting environments. Tree Physiology. 26(5). 595–604. 46 indexed citations

10.

Pendley, Charles, et al.. (2005). A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serum. Journal of Pharmaceutical and Biomedical Analysis. 38(4). 703–708. 7 indexed citations

11.

Kauffman, Catharine Lisa, Eiko Toichi, Thomas S. McCormick, et al.. (2004). A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis. Journal of Investigative Dermatology. 123(6). 1037–1044. 212 indexed citations

12.

Prabhakar, Uma, Manjula Reddy, Susan Spitz, et al.. (2004). Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. Journal of Immunological Methods. 291(1-2). 27–38. 68 indexed citations

13.

Pendley, Charles, Leo R. Fitzpatrick, Mary A. Davis, et al.. (1995). RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1015–1022. 34 indexed citations

14.

Bertrand, Philìppe, Georg Andrees Böhme, Christiane Durieux, et al.. (1994). Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists. European Journal of Pharmacology. 262(3). 233–245. 29 indexed citations

15.

Böhme, Georg Andrees, Philìppe Bertrand, Claude Guyon, et al.. (1994). The Ureidoacetamides, a Novel Family of Non‐peptide CCK‐B/Gastrin Antagonists. Annals of the New York Academy of Sciences. 713(1). 118–120. 10 indexed citations

16.

Pendley, Charles, et al.. (1993). The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1348–1354. 33 indexed citations

17.

Fitzpatrick, Leo R., Charles Pendley, G.E. Martin, et al.. (1990). RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 450–455. 17 indexed citations

18.

Pendley, Charles, et al.. (1989). An LTC4 binding site in gastric mucosa is shared with glutathione. Prostaglandins. 38(2). 237–250. 3 indexed citations

19.

Dugan, Laura L., Paul Demediuk, Charles Pendley, & L. A. Horrocks. (1986). Separation of phospholipids by high-performance liquid chromatography: All major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamine. Journal of Chromatography B Biomedical Sciences and Applications. 378(2). 317–327. 82 indexed citations

20.

Pendley, Charles. (1983). Language Policy and Social Transf ormation in Contemporary Singapore. Asian journal of social science. 11(1). 46–58. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact